(Photo by Emma McIntyre/Getty Images) Ayesha Curry continues to keep it real and she recently opened up about how postpartum depression led her to a botched boob job. The chef, author, mother, and wife of Steph Curry shared the story of her ill-fated plastic surgery during an interview with Working Mother. 5 fierce female celebs… Read More: Ayesha Curry blames postpartum depression for botched boob job »
Depression, obesity, and chronic pain are some of the most pressing global health concerns. New research may have found a drug that could one day tackle all of these three conditions. Scientists may have identified a protein inhibitor that could tackle three conditions at once. Almost 40 percent of adults in the United States were… Read More: Can blocking a single protein tackle depression, obesity, and pain? »
Since the the Food and Drug Administration (FDA) approved brexanolone as an intravenous infusion for the treatment of postpartum depression last week, we have been deluged with questions from patents, providers and the media regarding this new drug. Sage Therapeutics plans to market the drug under the name ZULRESSO and plans to launch in the… Read More: A Primer on Brexanolone (Zulresso) for Postpartum Depression »
Print this page March 5, 2019 — The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting… Read More: FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression »